13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
This Employment Law This Week® Monthly Rundown discusses the most important developments for employe...
Read More >
On Thursday, February 6, 2020 the U.S. House of Representatives passed the Protecting the Right to O...
Read More >
The California Court of Appeal, in its recent decision in Schmidt, et al. v. Superior Court, County ...
Read More >
Most corporate lawyers and investment professionals are probably familiar with the reporting require...
Read More >
Over the weekend, President Trump tweeted out that several prominent “‘Progressive’ Democrat Cong...
Read More >
2019 Update - The #MeToo movement, which has grown international in scope, is a wide-ranging campai...
Read More >